Latest Yiheng Capital Management, L.P. Stock Portfolio
Yiheng Capital Management, L.P. Performance:
2025 Q3: 3.05%YTD: 7.84%2024: 2.46%
Performance for 2025 Q3 is 3.05%, and YTD is 7.84%, and 2024 is 2.46%.
About Yiheng Capital Management, L.P. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Yiheng Capital Management, L.P. reported an equity portfolio of $678.1 Millions as of 30 Sep, 2025.
The top stock holdings of Yiheng Capital Management, L.P. are NOAH, , . The fund has invested 11.5% of it's portfolio in NOAH HLDGS LTD and 5.9% of portfolio in BILIBILI INC.
The fund managers got completely rid off GENERATION BIO CO (GBIO) stocks. They significantly reduced their stock positions in AKERO THERAPEUTICS INC (AKRO), BILIBILI INC and H WORLD GROUP LTD (HTHT). Yiheng Capital Management, L.P. opened new stock positions in ULTRAGENYX PHARMACEUTICAL IN (RARE), PONY AI INC and CELLEBRITE DI LTD (CLBT).
The top stock holdings of Yiheng Capital Management, L.P. are NOAH, , . The fund has invested 11.5% of it's portfolio in NOAH HLDGS LTD and 5.9% of portfolio in BILIBILI INC.
The fund managers got completely rid off GENERATION BIO CO (GBIO) stocks. They significantly reduced their stock positions in AKERO THERAPEUTICS INC (AKRO), BILIBILI INC and H WORLD GROUP LTD (HTHT). Yiheng Capital Management, L.P. opened new stock positions in ULTRAGENYX PHARMACEUTICAL IN (RARE), PONY AI INC and CELLEBRITE DI LTD (CLBT).
Yiheng Capital Management, L.P. Annual Return Estimates Vs S&P 500
Our best estimate is that Yiheng Capital Management, L.P. made a return of 3.05% in the last quarter. In trailing 12 months, it's portfolio return was 6.76%.
New Buys
| Ticker | $ Bought |
|---|---|
| ultragenyx pharmaceutical in | 6,790,800 |
| pony ai inc | 4,504,750 |
| cellebrite di ltd | 4,281,000 |
| generation bio co | 645,807 |
New stocks bought by Yiheng Capital Management, L.P.
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| akero therapeutics inc | -36.26 |
| bilibili inc | -26.06 |
| new oriental ed & technology | -12.74 |
| h world group ltd | -6.53 |
| noah hldgs ltd | -0.04 |
Yiheng Capital Management, L.P. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| generation bio co | -337,792 |
Yiheng Capital Management, L.P. got rid off the above stocks
Sector Distribution
Yiheng Capital Management, L.P. has about 80.1% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 80.1 |
| Healthcare | 16.3 |
| Technology | 3.6 |
Market Cap. Distribution
Yiheng Capital Management, L.P. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 80.1 |
| SMALL-CAP | 10.2 |
| MID-CAP | 7.4 |
| MICRO-CAP | 2.4 |
Stocks belong to which Index?
About 15.5% of the stocks held by Yiheng Capital Management, L.P. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 84.5 |
| RUSSELL 2000 | 15.5 |
Yiheng Capital Management, L.P. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Yiheng Capital Management, L.P.
Yiheng Capital Management, L.P. has 23 stocks in it's portfolio. About 37.1% of the portfolio is in top 10 stocks. AKRO proved to be the most loss making stock for the portfolio. VRDN was the most profitable stock for Yiheng Capital Management, L.P. last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACMR | acm resh inc | 1.62 | 280,201 | 10,964,300 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 1.34 | 191,076 | 9,072,290 | reduced | -36.26 | ||
| API | agora inc | 0.30 | 533,547 | 2,038,150 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 0.25 | 69,058 | 1,676,040 | unchanged | 0.00 | ||
| CLBT | cellebrite di ltd | 0.63 | 231,031 | 4,281,000 | new | |||
| DBVT | dbv technologies s a | 0.97 | 656,309 | 6,563,090 | unchanged | 0.00 | ||
| DNLI | denali therapeutics inc | 1.01 | 469,981 | 6,824,120 | unchanged | 0.00 | ||
| GBIO | generation bio co | 0.10 | 105,524 | 645,807 | new | |||
| GBIO | generation bio co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HTHT | h world group ltd | 2.64 | 457,032 | 17,874,500 | reduced | -6.53 | ||
| IVA | inventiva sa | 2.26 | 2,644,930 | 15,314,100 | unchanged | 0.00 | ||
| JD | jd.com inc | 4.06 | 787,413 | 27,543,700 | unchanged | 0.00 | ||
| KYMR | kymera therapeutics inc | 1.02 | 122,605 | 6,939,440 | unchanged | 0.00 | ||
| NOAH | noah hldgs ltd | 11.48 | 6,717,350 | 77,854,100 | reduced | -0.04 | ||
| RARE | ultragenyx pharmaceutical in | 1.00 | 225,758 | 6,790,800 | new | |||
| RERE | atrenew inc | 2.15 | 3,163,120 | 14,550,300 | unchanged | 0.00 | ||
| TAL | tal education group | 0.51 | 309,240 | 3,463,490 | unchanged | 0.00 | ||
| TOUR | tuniu corp | 0.04 | 314,437 | 299,438 | unchanged | 0.00 | ||
| VRDN | viridian therapeutics inc | 1.59 | 500,261 | 10,795,600 | unchanged | 0.00 | ||
| YSG | yatsen hldg ltd | 0.13 | 96,328 | 872,732 | unchanged | 0.00 | ||